Gene Expression Profiling of Monozygotic Twins Affected by Psoriatic Arthritis
- PMID: 33692638
- PMCID: PMC7939499
- DOI: 10.2147/OARRR.S291391
Gene Expression Profiling of Monozygotic Twins Affected by Psoriatic Arthritis
Abstract
Introduction: Psoriatic Arthritis (PsA) is a multifactorial disease, where the relative burden of genetic, epigenetic and environmental factors in clinical course and damage accrual is not yet definitively clarified. In clinical practice, there is a real need for useful candidate biomarkers in PsA diagnosis and disease progression, by exploring its underlying transcriptomic and epigenomic mechanisms. This work aims to profile the transcriptome in monozygotic (MZ) twins with psoriatic arthritis (PsA) highly concordant for clinical presentation, but discordant for the radiographic outcomes' severity.
Methods: We describe i) the clinical case of two MZ twins; ii) their comparative gene expression profiling (HTA 2.0 Affymetrix) and iii) signal pathways and pathophysiological processes in which differentially expressed genes are involved (in silico analysis by the IPA software, QIAGEN).
Results: One hundred sixty-three transcripts and 36 coding genes (28 up and 8 down) were differentially expressed between twins, and in the brother with the most erosive form, the transcriptomic profiling highlights the overexpression of genes known to be involved in immunomodulatory processes and on a broad spectrum of PsA manifestations.
Discussion: Twins' clinical cases are still a gold mine in medical research: twin brothers are ideal experimental models in estimating the relative importance of genetic versus nongenetic components as determinants of complex phenotypes, non-Mendelian and multifactorial diseases as PsA.
Keywords: diseases in twin; environment–gene interaction; gene expression profiling; genetic; joint erosions; psoriatic arthritis.
© 2021 Angioni et al.
Conflict of interest statement
Prof. Dr. Alberto Cauli reports personal fees from Abbvie, BMS, Celgene, Galapagos, Janssen, MSD, Sanofi, Alfa Sigma, UCB, and Lilly, grants and personal fees from Pfizer and Novartis, and non-financial support from Roche, outside the submitted work. The authors declare that they have no other potential conflicts of interest for this work.
Figures
References
-
- Rahman P, Gladman DD, Schentag CT, Petronis A. Excessive paternal transmission in psoriatic arthritis. Arthritis Rheum. 1999;42(6):1228–1231. - PubMed
-
- Pedersen OB, Svendsen AJ, Ejstrup L, Skytthe A, Junker P. On the heritability of psoriatic arthritis. Disease concordance among monozygotic and dizygotic twins. Ann Rheum Dis. 2008;67(10):1417–1421. - PubMed
-
- Chandran V, Schentag CT, Brockbank JE, et al. Familial aggregation of psoriatic arthritis. Ann Rheum Dis. 2009;68(5):664–667. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
